144 related articles for article (PubMed ID: 17122988)
1. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus.
Lagarde SM; Ver Loren van Themaat PE; Moerland PD; Gilhuijs-Pederson LA; Ten Kate FJ; Reitsma PH; van Kampen AH; Zwinderman AH; Baas F; van Lanschot JJ
Ann Surg Oncol; 2008 Dec; 15(12):3459-70. PubMed ID: 18825457
[TBL] [Abstract][Full Text] [Related]
4. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
6. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.
Wang XW; Gao HJ; Fang DC
J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus: can biomarkers predict progression to malignancy?
Tischoff I; Tannapfel A
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):653-63. PubMed ID: 19072343
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences.
van Dekken H; Wink JC; Vissers KJ; van Marion R; Koppert LB; Tilanus HW; Siersema PD; Tanke HJ; Szuhai K; Hop WC
Genes Chromosomes Cancer; 2006 May; 45(5):516-25. PubMed ID: 16479570
[TBL] [Abstract][Full Text] [Related]
9. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in Barrett's metaplasia and its progression.
Izzo JG; Luthra R; Wu TT; Correa AM; Luthra M; Anandasabapathy S; Chao KS; Hung MC; Aggarwal B; Hittelman WN; Ajani JA
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S2-6. PubMed ID: 17449347
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
13. Advances in biomarkers for esophageal cancer.
Nagaraja V; Eslick GD
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1169-80. PubMed ID: 24134419
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
15. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression profiling of esophageal adenocarcinoma.
Hammoud ZT; Badve S; Zhao Q; Li L; Saxena R; Thorat MA; Morimiya A; Rieger KM; Kesler KA
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):829-34. PubMed ID: 19327504
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
20. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
